Trial Profile
A Randomised, Open-label, 3-period crossover study to compare the relative pulmonary bioavailability of fluticasone-propionate/formoterol BAI and pMDI in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Nov 2017
Price :
$35
*
At a glance
- Drugs Formoterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Mundipharma Research
- 15 Nov 2017 New trial record